keyword
https://read.qxmd.com/read/27976136/ivy-leaf-extract-ea-575%C3%A2-in-daily-practice-treatment-of-acute-bronchitis-in-schoolchildren
#21
JOURNAL ARTICLE
C Staiger, C Lang, T Wegener
No abstract text is available yet for this article.
December 2016: Planta Medica
https://read.qxmd.com/read/26098681/coadministration-of-hedera-helix-l-extract-enabled-mice-to-overcome-insufficient-protection-against-influenza-a-pr-8-virus-infection-under-suboptimal-treatment-with-oseltamivir
#22
JOURNAL ARTICLE
Eun-Hye Hong, Jae-Hyoung Song, Aeri Shim, Bo-Ra Lee, Bo-Eun Kwon, Hyuk-Hwan Song, Yeon-Jeong Kim, Sun-Young Chang, Hyeon Gun Jeong, Jong Geal Kim, Sang-Uk Seo, HyunPyo Kim, YongSoo Kwon, Hyun-Jeong Ko
Several anti-influenza drugs that reduce disease manifestation exist, and although these drugs provide clinical benefits in infected patients, their efficacy is limited by the emergence of drug-resistant influenza viruses. In the current study, we assessed the therapeutic strategy of enhancing the antiviral efficacy of an existing neuraminidase inhibitor, oseltamivir, by coadministering with the leaf extract from Hedera helix L, commonly known as ivy. Ivy extract has anti-inflammatory, antibacterial, antifungal, and antihelminthic properties...
2015: PloS One
https://read.qxmd.com/read/25875509/a-valuable-option-for-the-treatment-of-respiratory-diseases-review-on-the-clinical-evidence-of-the-ivy-leaves-dry-extract-ea-575%C3%A2
#23
REVIEW
Christopher Lang, Patricia Röttger-Lüer, Christiane Staiger
Preparations from ivy leaves (Hederae helicis folium, Hedera helix) dry extracts are well established in the treatment of different respiratory diseases. Until today, the efficacy and safety of ivy leaf preparations has been demonstrated in a variety of controlled clinical studies and non-interventional studies. These results were nearly exclusively obtained using the commercial ivy leaves dry extract EA 575®. This paper will provide information on the clinical data obtained with this special extract, showing the importance of those preparations as a valuable therapeutic option for the treatment of acute and chronic respiratory diseases...
August 2015: Planta Medica
https://read.qxmd.com/read/24981979/determination-of-saponins-and-flavonoids-in-ivy-leaf-extracts-using-hplc-dad
#24
JOURNAL ARTICLE
Miao Yu, Young June Shin, Nanyoung Kim, Guijae Yoo, SeonJu Park, Seung Hyun Kim
A new method for the determination of six compounds, chlorogenic acid, rutin, nicotiflorin, hederacoside C, hederasaponin B and α-hederin, in ivy leaf extracts using high-performance liquid chromatography with diode array detector was developed. The chromatographic separation was performed on a YMC Hydrosphere C18 analytical column using a gradient elution of 0.1% phosphoric acid and acetonitrile. The method was validated in terms of specificity, linearity (r(2) > 0.9999), precision [relative standard deviation (RSD) < 0...
April 2015: Journal of Chromatographic Science
https://read.qxmd.com/read/24325458/phytochemical-attributes-of-four-conventionally-extracted-medicinal-plants-and-cytotoxic-evaluation-of-their-extracts-on-human-laryngeal-carcinoma-hep2-cells
#25
JOURNAL ARTICLE
Ana Belščak-Cvitanović, Ksenija Durgo, Arijana Bušić, Jasna Franekić, Draženka Komes
The bioactive composition and cytotoxic and antioxidative/prooxidative effects of four medicinal plants: yarrow (Achillea millefolium L.), hawthorn (Crataegus oxyacantha L.), ground ivy (Glechoma hederacea L.), and olive (Olea europea L.) on human laryngeal carcinoma cell line (HEp2) were investigated. Water extracts of these plants obtained by infusion, maceration, and decoction were characterized for their polyphenol content and antioxidant capacity. Based on the extraction efficiency of polyphenols, the final extracts were obtained whose polyphenolic profile, polysaccharides, mineral content, and cytoprotective activities were determined...
February 2014: Journal of Medicinal Food
https://read.qxmd.com/read/23750808/intracuticular-wax-fixes-and-restricts-strain-in-leaf-and-fruit-cuticles
#26
JOURNAL ARTICLE
Bishnu Prasad Khanal, Eckhard Grimm, Sebastian Finger, Alfred Blume, Moritz Knoche
This paper investigates the effects of cuticular wax on the release of strain and on the tensile properties of enzymatically isolated cuticular membranes (CMs) taken from leaves of agave (Agave americana), bush lily (Clivia miniata), holly (Ilex aquifolium), and ivy (Hedera helix) and from fruit of apple (Malus × domestica), pear (Pyrus communis), and tomato (Lycopersicon esculentum). Biaxial strain release was quantified as the decrease in CM disc area following wax extraction. Stiffness, maximum strain and maximum force were determined in uniaxial tensile tests using strips of CM and dewaxed CMs (DCMs)...
October 2013: New Phytologist
https://read.qxmd.com/read/23607546/pharmacokinetics-of-hederacoside-c-an-active-ingredient-in-ag-npp709-in-rats
#27
JOURNAL ARTICLE
Ju Myung Kim, Ji Na Yoon, Ji Won Jung, Hye Duck Choi, Young June Shin, Chang Kyun Han, Hye Suk Lee, Hee Eun Kang
1. Hederacoside C (HDC) is one of the active ingredients in Hedera helix leaf extract (Ivy Ex.) and AG NPP709, a new botanical drug to treat acute respiratory infection and chronic inflammatory bronchitis. However, information regarding its pharmacokinetic properties remains limited. 2. Here, we report the pharmacokinetics of HDC in rats after intravenous administration of HDC (3, 12.5, and 25 mg/kg) and after oral administration of HDC, Ivy Ex., and AG NPP709 (equivalent to 12.5, 25, and 50 mg/kg HDC). 3. Linear pharmacokinetics of HDC were identified upon its intravenous administration at doses of 3-25 mg/kg...
November 2013: Xenobiotica; the Fate of Foreign Compounds in Biological Systems
https://read.qxmd.com/read/23128091/ipomea-hederacea-jacq-a-medicinal-herb-with-promising-health-benefits
#28
REVIEW
Muhammad Zia-Ul-Haq, Muhammad Riaz, Vincenzo De Feo
Ipomea hederacea Jacq. (kaladana or ivy leaf morning-glory), a member of the family Convolvulaceae, is used primarily for its seeds and recognized for its medicinal properties, especially in Asian countries. This medicinal herb contains various valuable chemical constituents such as ecdysteriods, steroidal glycosides, aromatic acids, triterpenes, amino acids, organic acids, mineral elements and vitamins. A number of pharmacological properties such as diuretic, anthelmintic, blood purifier, deobstruent, laxative, carminative and anti-inflammatory actions have been ascribed to this plant, besides its use to treat abdominal diseases, fevers, headache and bronchitis...
November 5, 2012: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/21130149/studies-on-the-anti-inflammatory-properties-of-plantago-erosa-leaf-extract-in-rodents
#29
JOURNAL ARTICLE
Chandana Choudhury Barua, Saumen Kanti Pal, Jayanti Datta Roy, Bhaben Buragohain, Archana Talukdar, Acheenta Gohain Barua, Prabodh Borah
ETHNOPHARMACOLOGICAL RELEVANCE: Leaves of Plantago erosa ex Roxb are used traditionally in Northeast India in different illnesses which include wounds, cuts, bruises, insect bites, poison-ivy rashes, minor sores and snakebite, etc. AIM OF THE STUDY: Plantago erosa is one of the commonly used medicinal plants in various inflammatory conditions in this region; however, due to paucity of scientific literature on its anti-inflammatory property, the present study was aimed at evaluating its anti-inflammatory activity in the leaves using in vivo models of inflammation...
March 8, 2011: Journal of Ethnopharmacology
https://read.qxmd.com/read/20976077/systematic-review-of-clinical-trials-assessing-the-effectiveness-of-ivy-leaf-hedera-helix-for-acute-upper-respiratory-tract-infections
#30
JOURNAL ARTICLE
Felix Holzinger, Jean-François Chenot
Introduction. Among nonantibiotic cough remedies, herbal preparations containing extracts from leaves of ivy (Hedera helix) enjoy great popularity. Objective. A systematic review to assess the effectiveness and tolerability of ivy for acute upper respiratory tract infections (URTIs). Methods. We searched for randomized controlled trials (RCTs), nonrandomized controlled clinical trials and observational studies evaluating the efficacy of ivy preparations for acute URTIs. Study quality was assessed by the Jadad score or the EPHPP tool...
2011: Evidence-based Complementary and Alternative Medicine: ECAM
https://read.qxmd.com/read/20446230/-use-of-herbal-medicine-in-german-children-prevalence-indications-and-motivation
#31
JOURNAL ARTICLE
M Hümer, G Scheller, T Kapellen, C Gebauer, H Schmidt, Wieland Kiess
BACKGROUND AND OBJECTIVES: Herbal medicine (phytotherapy) is increasingly used by the German population. But its use for children has been rarely analysed. This study determined prevalence, motivations and indications for the use of herbal medicine use. It also investigated parent-related variables associated with its use. METHODS: An anonymized questionnaire was filled in by parents of children and adolescents who attended the general pediatric out-patient department of two German university children's hospitals and the practice of two general pediatricians...
May 2010: Deutsche Medizinische Wochenschrift
https://read.qxmd.com/read/19434268/management-for-the-children-with-otitis-media-with-effusion-in-the-tertiary-hospital
#32
JOURNAL ARTICLE
Yun-Hoon Choung, You Ree Shin, Seong Jun Choi, Keehyun Park, Hun Yi Park, Jong Bin Lee, Dong Hee Han, Hison Kahng
OBJECTIVES: Recently, new evidence-based recommendations have been introduced for diagnosing and managing otitis media with effusion (OME) in children. However, there are some difficulties to follow the general guidelines in the tertiary hospitals. The purpose is to evaluate the efficiency of antibiotics or antihistamines for treatment of children with OME in the tertiary hospital with a randomized prospective clinical study. METHODS: Eighty-four children with OME who had been diagnosed in the tertiary hospital were randomized to receive 5 different medications for 2 weeks...
December 2008: Clinical and Experimental Otorhinolaryngology
https://read.qxmd.com/read/16918519/high-incidence-of-sensitization-to-ornamental-plants-in-allergic-rhinitis
#33
JOURNAL ARTICLE
V Mahillon, S Saussez, O Michel
BACKGROUND: A few indoor plants have been described as potential allergens, in single case reports of allergic rhinitis. There is no data evaluating the prevalence of allergic sensitization to these plants. AIM: The relationship between owning indoor ornamental plants with the risk to be sensitized has been evaluated in atopic rhinitis. METHODS: A group of 59 patients with allergic rhinitis were submitted to skin prick tests (SPT) using both the leafs of their own plant and commercial extracts of the most frequent airborne allergens...
September 2006: Allergy
https://read.qxmd.com/read/16860549/tolerance-safety-and-efficacy-of-hedera-helix-extract-in-inflammatory-bronchial-diseases-under-clinical-practice-conditions-a-prospective-open-multicentre-postmarketing-study-in-9657-patients
#34
MULTICENTER STUDY
S Fazio, J Pouso, D Dolinsky, A Fernandez, M Hernandez, G Clavier, M Hecker
In this postmarketing study 9657 patients (5181 children) with bronchitis (acute or chronic bronchial inflammatory disease) were treated with a syrup containing dried ivy leaf extract. After 7 days of therapy, 95% of the patients showed improvement or healing of their symptoms. The safety of the therapy was very good with an overall incidence of adverse events of 2.1% (mainly gastrointestinal disorders with 1.5%). In those patients who got concomitant medication as well, it could be shown that the additional application of antibiotics had no benefit respective to efficacy but did increase the relative risk for the occurrence of side effects by 26%...
January 2009: Phytomedicine
https://read.qxmd.com/read/16391481/open-trial-to-assess-aspects-of-safety-and-efficacy-of-a-combined-herbal-cough-syrup-with-ivy-and-thyme
#35
JOURNAL ARTICLE
Samuel Büechi, Roger Vögelin, Mónica Mennet von Eiff, Mac Ramos, Jörg Melzer
BACKGROUND AND OBJECTIVES: Changes in the symptoms of cough after treatment with a combined herbal preparation containing dry ivy leaf extract as main active ingredient, decoction of thyme and aniseed, and mucilage of marshmallow root (Weleda Hustenelixier, new formulation) and its tolerability were investigated in an open clinical trial ('Anwendungsbeleg'). PATIENTS AND METHODS: Between January and March 2004, 13 general practitioners recruited and treated 62 patients with a mean age of 50 years (range 16-89)...
December 2005: Research in Complementary and Natural Classical Medicine
https://read.qxmd.com/read/15544055/hplc-profiling-and-quantification-of-active-principles-in-leaves-of-hedera-helix-l
#36
JOURNAL ARTICLE
B Demirci, M Goppel, F Demirci, G Franz
Ivy (Hedera helix L., Araliaceae), is an evergreen medicinal and ornamental plant. Depending on leaf polymorphism different shaped ivy leaves were extracted and subsequently analyzed by reversed-phase high performance liquid chromatography (RP-HPLC). Quantitative determination of its most prominent saponins hederacoside C (1) and alpha-hederin (2) from different ivy leaf extracts were detected, validated and optimized for quick profiling. The linearity of response, repeatability and reproducibility of the applied RP-HPLC method are reported...
October 2004: Die Pharmazie
https://read.qxmd.com/read/12006725/-treatment-of-chronic-bronchitis-with-ivy-leaf-special-extract-multicenter-post-marketing-surveillance-study-in-1-350-patients
#37
MULTICENTER STUDY
M Hecker, F Runkel, A Voelp
BACKGROUND AND OBJECTIVES: The changes of clinical symptoms and the tolerability of Prospan((R)) acute Effervescent Cough Tablets were investigated in a multicenter, prospective post-marketing surveillance (PMS) study focusing on patients with chronic bronchitis. PATIENTS AND METHODS: The study included 1,350 male and female patients aged 4 years and above who were treated in one of 135 participating medical practices and who suffered from chronic bronchitis (with or without airway obstruction)...
April 2002: Research in Complementary and Natural Classical Medicine
https://read.qxmd.com/read/2521239/quantitation-and-cloning-of-human-urushiol-specific-peripheral-blood-t-cells-isolation-of-urushiol-triggered-suppressor-t-cells
#38
JOURNAL ARTICLE
R S Kalish, C Morimoto
A limiting dilution assay was developed to quantitate urushiol (the antigen of poison ivy; Toxicodendron radicans) specific T cells from peripheral blood of a patient with a history of rhus (poison ivy) dermatitis. It was found that maximal sensitivity with minimal nonspecific proliferation could be produced with the use of 5 U/ml of recombinant IL2 added to the assay on day 6. This donor was found to have a frequency of urushiol specific peripheral blood T cells of (1/2935). Five interleukin 2 (IL2) dependent urushiol specific T-cell clones were generated from the peripheral blood of this patient...
January 1989: Journal of Investigative Dermatology
https://read.qxmd.com/read/2458387/urushiol-poison-ivy-triggered-suppressor-t-cell-clone-generated-from-peripheral-blood
#39
JOURNAL ARTICLE
R S Kalish, C Morimoto
Allergic contact dermatitis to Toxicodendron radicans (poison ivy) is mediated by the hapten urushiol. An urushiol-specific, interleukin 2 (IL-2)-dependent T cell clone (RLB9-7) was generated from the peripheral blood of a patient with a history of allergic contact dermatitis to T. radicans. This clone proliferated specifically to both leaf extract and pure urushiol. Although the clone had the phenotype CD3+CD4+CD8+, proliferation to antigen was blocked by anti-CD8 and anti-HLA-A, B, C, but not by anti-CD4, suggesting that CD4 was not functionally associated with the T cell receptor...
September 1988: Journal of Clinical Investigation
https://read.qxmd.com/read/315414/in-vitro-studies-of-poison-oak-immunity-i-in-vitro-reaction-of-human-lymphocytes-to-urushiol
#40
JOURNAL ARTICLE
V S Byers, W L Epstein, N Castagnoli, H Baer
Poison oak, ivy, and sumac dermatitis is a T-cell-mediated reaction against urushiol, the oil found in the leaf of the plants. This hapten is extremely lipophilic and concentrates in cell membranes. A blastogenesis assay employing peripheral blood lymphocytes obtained from humans sensitized to urushiol is described. The reactivity appears 1--3 wk after exposure and persists from 6 wk to 2 mon. The dose-response range is narrow, with inhibition occurring at higher antigen concentrations. Urushiol introduced into the in vitro culture on autologous lymphocytes, erythrocytes and heterologous erythrocytes produces equal results as measured by the optimal urushiol dose, the intensity of reaction, and the frequency of positive reactors...
November 1979: Journal of Clinical Investigation
keyword
keyword
6855
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.